Drug Profile
Research programme: Alzheimer's disease therapeutics - Neuro-Hitech
Alternative Names: 2,3,4-Trihydroxybenzophenone; 4-Amino 1,1'-azobenzene-3,4'-disulfonic acid sodium saltLatest Information Update: 25 Feb 2014
Price :
$50
*
At a glance
- Originator Neuro-Hitech
- Class
- Mechanism of Action Amyloid beta-protein inhibitors; Tau protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 25 Feb 2014 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 02 Nov 2006 Preclinical trials in Alzheimer's disease in USA (unspecified route)